首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   376643篇
  免费   44542篇
  国内免费   518篇
  2018年   3220篇
  2017年   3061篇
  2016年   4161篇
  2015年   5364篇
  2014年   6601篇
  2013年   8867篇
  2012年   10193篇
  2011年   10362篇
  2010年   6841篇
  2009年   6605篇
  2008年   9166篇
  2007年   9339篇
  2006年   9148篇
  2005年   8718篇
  2004年   8542篇
  2003年   8405篇
  2002年   8153篇
  2001年   23754篇
  2000年   23728篇
  1999年   18157篇
  1998年   5086篇
  1997年   5476篇
  1996年   5032篇
  1995年   4562篇
  1994年   4461篇
  1993年   4489篇
  1992年   13645篇
  1991年   13440篇
  1990年   12560篇
  1989年   12430篇
  1988年   11482篇
  1987年   10491篇
  1986年   9484篇
  1985年   9325篇
  1984年   7241篇
  1983年   6341篇
  1982年   4545篇
  1981年   3947篇
  1980年   3735篇
  1979年   6668篇
  1978年   5160篇
  1977年   4686篇
  1976年   4142篇
  1975年   4673篇
  1974年   4891篇
  1973年   4854篇
  1972年   4290篇
  1971年   3998篇
  1970年   3466篇
  1969年   3321篇
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
81.
82.
Indirect evidence has suggested that the Msh2-Msh6 mispair-binding complex undergoes conformational changes upon binding of ATP and mispairs, resulting in the formation of Msh2-Msh6 sliding clamps and licensing the formation of Msh2-Msh6-Mlh1-Pms1 ternary complexes. Here, we have studied eight mutant Msh2-Msh6 complexes with defective responses to nucleotide binding and/or mispair binding and used them to study the conformational changes required for sliding clamp formation and ternary complex assembly. ATP binding to the Msh6 nucleotide-binding site results in a conformational change that allows binding of ATP to the Msh2 nucleotide-binding site, although ATP binding to the two nucleotide-binding sites appears to be uncoupled in some mutant complexes. The formation of Msh2-Msh6-Mlh1-Pms1 ternary complexes requires ATP binding to only the Msh6 nucleotide-binding site, whereas the formation of Msh2-Msh6 sliding clamps requires ATP binding to both the Msh2 and Msh6 nucleotide-binding sites. In addition, the properties of the different mutant complexes suggest that distinct conformational states mediated by communication between the Msh2 and Msh6 nucleotide-binding sites are required for the formation of ternary complexes and sliding clamps.  相似文献   
83.
84.
L-myo-Inositol-1-phosphate synthase has been found to have at least a 5-fold preference for the beta-anomer of its natural substrate D-Glc-6-P. The alpha-anomer appears to be an inhibitor of the reaction and may be converted to product as well. As well as showing an enzymatic preference for the equatorial C-1 hydroxyl of D-Glc-6-P, our results suggest that it is the pyranose form of D-Glc-6-P that binds to the enzyme and that ring-opening is an enzymatic step. We have also found D-2-dGlc-6-P, D-2-F-2-dGlc-6-P, and D-Man-6-P each to be both competitive inhibitors and substrates that are converted to inositol phosphates by the synthase. D-Allose-6-P is a weak inhibitor of the enzyme, but not a substrate. D-Gal-6-P is neither substrate nor inhibitor. Thus the specificity of the synthase with respect to single position epimers of D-Glc-6-P increases in the order C1 less than C2 much less than C3 less than C4.  相似文献   
85.
86.
87.
88.
Intraperitoneal stimulation of adoptively sensitized rats with bacterial antigen promotes the localization of lymphoblasts at the site of antigen deposition. Lymphoblast extravasation activity (LEA) is generated only when specifically immune donor lymphocytes and the recipients of these cells share at least on Ag-B haplotype. However, if the specificity criteria for its formation are satisfied, LEA promotes the local development of lymphoblasts of all available specificities and irrespective of their Ag-B genotype. Allogeneic lymphoblasts do not participate actively in the delayed inflammatory reaction even when they are passively recruited into exudates. The results suggest that LEA is a T cell-derived mediator that amplifies the delayed type hypersensitivity reaction by directing recently activated lymphocytes into lesions.  相似文献   
89.
90.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号